Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K L March

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Seminars in Interventional Cardiology : SIIC|September 1, 1996
Methods of local gene delivery to vascular tissuesK L March
Circulation Research|March 5, 1998
Gene therapy for restenosis: getting nearer the heart of the matterS Baek, K L March
Circulation|July 10, 1998
Heparin responsiveness in vitro as a prognostic tool for vascular graft stenosis: a tale of two cell types?J R Sindermann, K L March
Seminars in Interventional Cardiology : SIIC|March 1, 1996
MicrospheresR L Wilensky, K L March
Journal of the American College of Cardiology|February 1, 1989
Molecular cardiology: new avenues for the diagnosis and treatment of cardiovascular diseaseD R Hathaway, K L March
Oncogene|July 3, 1999
Hyperplasia in multiple smooth muscle tissues in transgenic mice expressing a temperature-sensitive SV40 T-antigen under the control of smooth muscle alpha-actin regulatory sequencesK L March, G Sandusky, L Fan
Journal of Virology|November 1, 1996
Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapyN Mittereder, K L March, B C Trapnell
Arteriosclerosis, Thrombosis, and Vascular Biology|April 9, 1999
NGF activates similar intracellular signaling pathways in vascular smooth muscle cells as PDGF-BB but elicits different biological responsesR Kraemer, H Nguyen, K L March, et al.
American Heart Journal|October 1, 1991
Direct intraarterial wall injection of microparticles via a catheter: a potential drug delivery strategy following angioplastyR L Wilensky, K L March, D R Hathaway
Human Gene Therapy|January 1, 1995
Pharmacokinetics of adenoviral vector-mediated gene delivery to vascular smooth muscle cells: modulation by poloxamer 407 and implications for cardiovascular gene therapyK L March, J E Madison, B C Trapnell
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Seminars in Interventional Cardiology : SIIC|September 1, 1996
Methods of local gene delivery to vascular tissuesK L March
Circulation Research|March 5, 1998
Gene therapy for restenosis: getting nearer the heart of the matterS Baek, K L March
Circulation|July 10, 1998
Heparin responsiveness in vitro as a prognostic tool for vascular graft stenosis: a tale of two cell types?J R Sindermann, K L March
Seminars in Interventional Cardiology : SIIC|March 1, 1996
MicrospheresR L Wilensky, K L March
Journal of the American College of Cardiology|February 1, 1989
Molecular cardiology: new avenues for the diagnosis and treatment of cardiovascular diseaseD R Hathaway, K L March
Oncogene|July 3, 1999
Hyperplasia in multiple smooth muscle tissues in transgenic mice expressing a temperature-sensitive SV40 T-antigen under the control of smooth muscle alpha-actin regulatory sequencesK L March, G Sandusky, L Fan
Journal of Virology|November 1, 1996
Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapyN Mittereder, K L March, B C Trapnell
Arteriosclerosis, Thrombosis, and Vascular Biology|April 9, 1999
NGF activates similar intracellular signaling pathways in vascular smooth muscle cells as PDGF-BB but elicits different biological responsesR Kraemer, H Nguyen, K L March, et al.
American Heart Journal|October 1, 1991
Direct intraarterial wall injection of microparticles via a catheter: a potential drug delivery strategy following angioplastyR L Wilensky, K L March, D R Hathaway
Human Gene Therapy|January 1, 1995
Pharmacokinetics of adenoviral vector-mediated gene delivery to vascular smooth muscle cells: modulation by poloxamer 407 and implications for cardiovascular gene therapyK L March, J E Madison, B C Trapnell
Pageof 5